Cardinal Health, Inc. (CAH)

In the past six months, Cardinal Health's stock has experienced various movements. The stock price increased by 26.09% over the last 12 months, but saw a year-to-date return of -6.91% and a decrease of 9.90% in the past month. The company announced its third-quarter fiscal year 2026 earnings, reporting $3.17 earnings per share, which beat analysts' consensus estimates, but revenue missed expectations. The company raised its full-year fiscal 2026 non-GAAP EPS and adjusted free cash flow guidance. The Board of Directors approved an increase to its quarterly dividend to $0.5158 per share. JPMorgan Chase & Co. lowered its price target on Cardinal Health from $243.00 to $215.00, maintaining a neutral rating.

Cardinal Health experiences demand seasonality, particularly for certain products and services. The company has implemented a Reserved Inventory Program to help laboratories and health systems pre-order respiratory diagnostics more accurately. Analysis of Cardinal Health's stock performance also suggests seasonal patterns in its monthly returns.

Cardinal Health, Inc. is a multinational healthcare services and products company headquartered in Dublin, Ohio, operating primarily in the Drug, Cosmetic & Toiletry Wholesaling and Medical Supplies Wholesaling industries. The company distributes pharmaceuticals and medical products to healthcare providers worldwide. Its Pharmaceutical segment distributes branded, generic, and specialty pharmaceuticals, operates a radiopharmacy network, and provides services to manufacturers and providers. The Medical segment manufactures medical and surgical products and offers supply chain services.

Cardinal Health has a significant global presence, operating in over 30 countries and serving more than 100,000 locations, including over 75% of hospitals in the United States. Its reach extends across the Americas, EMEA, and Asia-Pacific regions.

In the past year, Cardinal Health has focused on its commitment to ESG initiatives, releasing its Fiscal 2023 ESG Report. The company reduced Scope 1 and Scope 2 greenhouse gas emissions by 13% from a fiscal 2019 base year and conducted a life cycle assessment showing that reprocessed compression sleeves had a 40% lower carbon footprint. Cardinal Health has also been improving its supplier due diligence program and supply chain mapping.

Cardinal Health's ownership is predominantly institutional, with major shareholders including The Vanguard Group, BlackRock, Inc., and State Street Corp. Individual investors and public companies also hold a notable percentage of the stock. Recent insider trading activity includes sales by officers.